mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0003 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |